Qsymia

Analyst: Vivus generic threats a positive for obesity market
Fierce Pharma
Fri, 04/17/15 - 10:35 am
Vivus
obesity
generics
Qsymia
Teva Pharmaceuticals
Actavis
VIVUS Files Lawsuit Against Teva for Infringement of Qsymia Patents
Yahoo
Thu, 04/16/15 - 09:23 am
Vivus
Teva Pharmaceutical
patents
Qsymia
Vivus to slash obesity salesforce by one-third, turn to digital instead
Fierce Pharma Marketing
Wed, 04/1/15 - 05:33 pm
Vivus
drug reps
layoffs
Qsymia
Vivus, Arena, Or Orexigen - Which Will Win The Anti-Obesity Market Share Race?
Seeking Alpha
Tue, 03/24/15 - 08:30 am
Vivus
Orexigen
Arena Pharmaceuticals
Contrave
Belviq
Qsymia
obesity
Can Orexigen Win Where Obesity-Drug Rivals Failed?
Investopedia
Thu, 03/19/15 - 07:58 am
obesuty
Orexigen
Contrave
Qsymia
Belviq
Vivus: Teva Wants To Make Generic Qsymia - Can This Be Good?
Seeking Alpha
Wed, 03/11/15 - 03:17 pm
Vivus
Teva Pharmaceutical
generics
Qsymia
Vivus' Suit Against Actavis Gets Some Dates - Is Trouble Ahead?
Seeking Alpha
Sat, 03/7/15 - 11:18 am
Vivus
Actavis
Qsymia
Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus
TheStreet.com
Sat, 02/21/15 - 09:44 am
obesity
Orexigen
Arena
Vivus
Belviq
Contrave
Qsymia
Vivus' Qsymia Experiencing Both Prescription Growth And Market Share Erosion
Seeking Alpha
Wed, 02/18/15 - 10:52 am
Vivus
Qsymia
obesity
Orexigen
Arena Pharmaceuticals
Contrave
Belviq
With Flat Qsymia Sales, Vivus May Shift Focus To Stendra/Spedra
Seeking Alpha
Fri, 02/6/15 - 08:08 am
Vivus
Qsymia
Stendra
Spedra
erectile dysfunction
5 Obesity Stocks Investors Are Watching
Yahoo/Benzinga
Thu, 01/15/15 - 08:53 am
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
APD334
Vivus
Qsymia
EnteroMedics
devices
Maestro System
Novo Nordisk
Saxenda
Is Vivus Headed Towards An Unfortunate Ending?
Seeking Alpha
Mon, 12/29/14 - 11:10 am
Vivus
Qsymia
Arena And Vivus Investors Need To Grasp Implications Of Orexigen
Seeking Alpha
Fri, 12/19/14 - 04:08 pm
Arena Pharmaceuticals
Vivus
Contrave
Belviq
Qsymia
Vivus Tries To Lead Obesity Space With Insurance Coverage
Seeking Alpha
Tue, 12/16/14 - 08:18 am
Vivus
obesity
insurance
Qsymia
VIVUS Announces Favorable Formulary Positioning for Qsymia
Yahoo
Mon, 12/15/14 - 08:01 am
Vivus
Qsymia
formulary
Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals
Adam on Biotech Stocks
Fri, 12/12/14 - 12:33 pm
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
Vivus
Qsymia
The Odds Of Success For The New Obesity Drugs
CP Wire
Mon, 12/8/14 - 11:45 am
obesity
Belviq
Contrave
Qsymia
Arena Pharmaceuticals
Vivus
Orexigen
Vivus awarded two patents for Qsymia
Seeking Alpha
Wed, 11/26/14 - 12:05 pm
Vivus
Qsymia
patents
Vivus announces journal publication of Qsymia study results in type 2 diabetes
Seeking Alpha
Mon, 10/6/14 - 11:06 am
Vivus
Qsymia
type 2 diabetes
Selling Obesity Drugs to Americans Shouldn't Be This Hard
Bloomberg/Businessweek
Mon, 09/15/14 - 09:18 am
obesity
Orexigen
Contrave
Qsymia
Belviq
Arena Pharmaceuticals
Eisai

Pages